CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 32 enrolled
Drug / intervention
Oxytocin +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01829516
NCT01829516Phase 4Completed
CompareCT.gov

The Effects of Intranasal Oxytocin on Social Cognition, Implicit Preferences and Craving in Moderate to Heavy Social Alcohol Drinkers

University of California, San Francisco·interventional·Posted Apr 11, 2013·Updated Jul 27, 2016

In Brief

A Phase 4 clinical trial evaluating Oxytocin and Placebo for AOD Use, Abuse, and Dependence. Completed, enrolled 32 participants across 1 site.

Detailed Summary

This is a randomized, placebo controlled, double blind crossover study of the effects of intranasal oxytocin on social cognition, implicit preferences and craving in moderate to heavy social alcohol drinkers.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAOD Use, Abuse, and Dependence
CountriesUnited States
Collaborators--

Timeline

Phase 4CompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedApr 11, 2013
Enrollment StartMay 1, 2013
Primary CompletionMay 1, 2014
Study CompletionNov 1, 2014
TodayJul 2, 2026
Enrollment to primary: 1 yearPosted 13.2 years ago

Interventions

Oxytocindrug

Intranasal oxytocin

Placebodrug

Intranasal placebo